| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |